Thrombocytopenia in congenital heart disease patients

References

• Khairy P. Thrombosis in congenital heart disease. Expert Rev Cardiovasc Ther 2013;11:1579–1582
   PubMedGoogle Scholar
• Monagle P. Thrombosis: Congenital heart disease and thrombosis: What do we know? Nat Rev Cardiol 2014;11:132–134
   PubMedGoogle Scholar
• Kajimoto H, Nakazawa M, Murasaki K, Mori Y, Tanoue K, Kasanuki H, Nakanishi T. Increased thrombogenesity in patients with cyanotic congenital heart disease. Circ J 2007;71:948–953
   PubMedGoogle Scholar
• Sakazaki H, Niwa K, Echigo S, Akagi T, Nakazawa M. Predictive factors for long-term prognosis in adults with cyanotic congenital heart disease – Japanese multi-center study. Int J Cardiol 2007;120:72–78
   PubMedGoogle Scholar
• van der Bom JG, Heckbert SR, Lumley T, Holmes CE, Cushman M, Folsom AR, Rosendaal FR, Psaty BM. Platelet count and the risk for thrombosis and death in the elderly. J Thromb Haemost 2009;7:399–405
   PubMed Web of Science ®Google Scholar
• Chan KL, Currie PJ, Seward JB, Hagler DJ, Mair DD, Tajik AJ. Comparison of three Doppler ultrasound methods in the prediction of pulmonary artery pressure. J Am Coll Cardiol 1987;9:549–554
   PubMed Web of Science ®Google Scholar
• Spence MS, Balaratnam MS, Gatzoulis MA. Clinical update: Cyanotic adult congenital heart disease. Lancet 2007;370:1530–1532
   PubMed Web of Science ®Google Scholar
• Giglia TM, Massicotte MP, Tweddell JS, Barst RJ, Bauman M, Erickson CC, Feltes TF, Foster E, Hinoki K, Ichord RN, et al. American Heart Association Congenital Heart Defects Committee of the Council on Cardiovascular Disease in the Young, Council on Cardiovascular and Stroke Nursing, Council on Epidemiology and Prevention, and Stroke Council. Prevention and treatment of thrombosis in pediatric and congenital heart disease: A scientific statement from the American Heart Association. Circulation 2013;128:2622–2703
   PubMed Web of Science ®Google Scholar
• Osthaus WA, Boethig D, Johanning K, Rahe-Meyer N, Theilmeier G, Breymann T, Suempelmann R. Whole blood coagulation measured by modified thrombelastography (ROTEM) is impaired in infants with congenital heart diseases. Blood Coagul Fibrinolysis 2008;19:220–225
   PubMedGoogle Scholar
• Lill MC, Perloff JK, Child JS. Pathogenesis of thrombocytopenia in cyanotic congenital heart disease. Am J Cardiol 2006;98:254–258
   PubMedGoogle Scholar
• Horigome H, Hiramatsu Y, Shigeta O, Nagasawa T, Matsui A. Overproduction of platelet microparticles in cyanotic congenital heart disease with polycythemia. J Am Coll Cardiol 2002;39:1072–1077
   PubMed Web of Science ®Google Scholar
• Lill MC, Perloff JK, Child JS. Pathogenesis of thrombocytopenia in cyanotic congenital heart disease. Am J Cardiol 2006;98:254–258
   PubMedGoogle Scholar
• Horigome H, Hiramatsu Y, Shigeta O, Nagawasa T, Matsui A. Overproduction of platelet microparticles in cyanotic congenital heart disease with polycythemia. J Am Coll Cardiol 2002;39:1072–1077
   PubMed Web of Science ®Google Scholar
• Candice KS, John TG, Eli K, Michelle AH. Pulmonary thrombosis in adults with Eisenmenger syndrome. J Am Coll Cardiol 2003;42:1982–1987
   PubMedGoogle Scholar
• Niwa K, Perloff JK, Bhuta SM, Laks H, Drinkwater DC, Child JS, Miner PD. Structural abnormalities of great arterial walls in congenital heart disease: Light and electron microscopic analyses. Circulation 2001;103:393–400
   PubMed Web of Science ®Google Scholar
• Broberg CS, Ujita M, Prasad S, Li W, Rubens M, Bax BE, Davidson SJ, Bouzas B, Gibbs JS, Burman J, et al. Pulmonary arterial thrombosis in Eeisenmenger syndrome is associated with biventricular dysfunction and decreased pulmonary flow velocity. J Am Coll Cardiol 2007;50:634–642
   PubMed Web of Science ®Google Scholar
• Silversides CK, Granton JT, Konen E, Hart MA, Webb GD, Therrien J. Pulmonary thrombosis in adults with Eisenmenger syndrome. J Am Coll Cardiol 2003;42:1982–1987
   PubMed Web of Science ®Google Scholar
• Martínez-Quintana E, Miranda-Calderín G, Ugarte-Lopetegui A, Rodríguez-González F. Rehabilitation program in adult congenital heart disease patients with pulmonary hypertension. Congenit Heart Dis 2010;5:44–50
   PubMed Web of Science ®Google Scholar
• Jensen AS, Johansson PI, Bochsen L, Idorn L, Sørensen KE, Thilén U, Nagy E, Furenäs E, Søndergaard L. Fibrinogen function is impaired in whole blood from patients with cyanotic congenital heart disease. Int J Cardiol 2013;167:2210–2214
   PubMedGoogle Scholar
• Jensen AS, Johansson PI, Idorn L, Sørensen KE, Thilén U, Nagy E, Furenäs E, Søndergaard L. The haematocrit – An important factor causing impaired haemostasis in patients with cyanotic congenital heart disease. Int J Cardiol 2013;167:1317–1321
   PubMedGoogle Scholar
• Vannucchi AM, Barbui T. Thrombocytosis and thrombosis. Hematology Am Soc Hematol Educ Program 2007;1:363–370
   Google Scholar
• Aksu K, Donmez A, Keser G. Inflammation-induced thrombosis: Mechanisms, disease associations and management. Curr Pharm Des 2012;18:1478–1493
   PubMed Web of Science ®Google Scholar
• Wagner DD, Burger PC. Platelets in inflammation and thrombosis. Arterioscler Thromb Vasc Biol 2003;23:2131–2137
   PubMed Web of Science ®Google Scholar
• Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD. Mean platelet volume: A link between thrombosis and inflammation? Curr Pharm Des 2011;17:47–58
   PubMed Web of Science ®Google Scholar
• Kreutz RP, Owens J, Breall JA, Lu D, von der Lohe E, Bolad I, Sinha A, Flockhart DA. C-reactive protein and fibrin clot strength measured by thrombelastography after coronary stenting. Blood Coagul Fibrinolysis 2013;24:321–326
   PubMedGoogle Scholar
• Grad E, Danenberg HD. C-reactive protein and atherothrombosis: Cause or effect? Blood Rev 2013;27:23–29
   PubMedGoogle Scholar
• Dimopoulos K, Diller GP, Koltsida E, Pijuan-Domenech A, Papadopoulou SA, Babu-Narayan SV, Salukhe TV, Piepoli MF, Poole-Wilson PA, Best N, et al. Prevalence, predictors, and prognostic value of renal dysfunction in adults with congenital heart disease. Circulation 2008;117:2320–2328
   PubMed Web of Science ®Google Scholar
• Martínez-Quintana E, Rodríguez-González F, Fábregas-Brouard M, Nieto-Lago V. Serum and 24-hour urine analysis in adult cyanotic and noncyanotic congenital heart disease patients. Congenit Heart Dis 2009;4:147–152
   PubMedGoogle Scholar
• Khairy P. Thrombosis in congenital heart disease. Expert Rev Cardiovasc Ther 2013;11:1579–1582
   PubMedGoogle Scholar
• Levin E, Wu J, Devine DV, Alexander J, Reichart C, Sett C, Seear M. Hemostatic parameters and platelet activation marker expression in cyanotic and acyanotic pediatric patients undergoing cardiac surgery in the presence of tranexamic acid. Thromb Haemost 2000;83:54–59
   PubMedGoogle Scholar